Clinical Trials Directory

Trials / Completed

CompletedNCT04593095

Nurturing and Quiet Intervention: NeuroN-QI

Nurturing and Quiet Intervention (NeuroN-QI) on Preterm Infants' Neurodevelopment and Maternal Stress and Anxiety: Protocol of a Pilot Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
St. Justine's Hospital · Academic / Other
Sex
All
Age
26 Weeks – 32 Weeks
Healthy volunteers
Accepted

Summary

The current state of knowledge reveals that the development of the brain of preterm infants is influenced by specific neonatal experiences during hospitalization, such as environmental sensory stimulation (light and noise), as well as physical and emotional proximity to mothers. However, there is a lack of evidence regarding the benefits that could be associated with the combination of care interventions to improve the health outcomes of preterm infants and their mothers, and in particular the development of the brain of infants during their hospitalization in the neonatal unit. The aim of this pilot study is to assess the feasibility and acceptability of a developmental care intervention including periods of nurturing between mothers and their infant (skin-to-skin contact and auditory stimulation) to promote physical and emotional proximity and a quiet period (controlled light and noise levels and olfactory stimulation in incubators) and to estimate the effect of this intervention on infants' neurodevelopment as well as on maternal stress and anxiety.

Conditions

Interventions

TypeNameDescription
OTHERNeuroN-QISSC session lasting 2-hr during the day 4 times/wk including a 15-min of auditory stimulation with maternal voice and controlled levels of NICU light and noise followed by a 1-hr quiet period where infants will rest in their incubator/crib with olfactory stimulation and where the control of light and noise levels will be continued.

Timeline

Start date
2021-06-01
Primary completion
2024-06-01
Completion
2024-06-01
First posted
2020-10-19
Last updated
2025-03-20

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04593095. Inclusion in this directory is not an endorsement.